SB 514

  • Indiana Senate Bill
  • 2025 Regular Session
  • Introduced in Senate
  • Senate
  • House
  • Governor

Chimeric antigen receptor T-cell therapy.

Abstract

Provides that a policy of accident and sickness insurance or health maintenance organization contract that provides coverage for chimeric antigen receptor (CAR) T-cell therapy may not refuse to contract or deny coverage for the administration of any CAR T-cell therapy by any provider that qualifies as a certified health care facility by the federal Food and Drug Administration for the applicable CAR T-cell therapy.

Bill Sponsors (1)

Votes


No votes to display

Actions


Jan 16, 2025

Senate

Authored by Senator Leising

Senate

First reading: referred to Committee on Health and Provider Services

  • Reading-1
  • Referral-Committee
Health and Provider Services

Bill Text

Bill Text Versions Format
Introduced Senate Bill (S) PDF

Related Documents

Document Format
Fiscal Note: SB0514.01.INTR.FN001 PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Indiana General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.